Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working Party-Reference-Cited by-同舟云学术

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working Party

Published:2012-09 Issue:3 Volume:77 Page:605-610
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Berghmans T.,Lafitte J.J.,Giner V.,Berchier M.C.,Scherpereel A.,Lewin D.,Paesmans M.,Meert A.P.,Bosschaerts T.,Leclercq N.,Sculier J.P.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

2. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature;Berghmans;Lung Cancer,2005

3. Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials;Song;J Thorac Oncol,2010

4. Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials;Lim;J Thorac Oncol,2009

5. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer;Depierre;J Clin Oncol,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis;JNCI Cancer Spectrum;2024-03-23

2. Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis;Frontiers in Oncology;2022-09-21

3. The optimal neoadjuvant regimen for nonsmall cell lung cancer: A meta-analysis;Medicine;2022-08-26

4. Les coûts du cancer du poumon;Revue des Maladies Respiratoires Actualités;2018-10

5. Review of economic analyses of treatment for non-small–cell lung cancer (NSCLC);Expert Review of Pharmacoeconomics & Outcomes Research;2018-06-14